Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate Anticoagulation During MARS Treatment
NCT00695617Phase 3Unknown
- Sponsor
- UZ Leuven
- Start
- Jul 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of trisodium citrate in liver failure (2 arms), sponsored by UZ Leuven. Primary endpoint: Extracorporeal circuit coagulation events at 6 hours. Status: unknown.
02
Drugs
trisodium citrate
03
Conditions
liver failure
Beyond the preview
Go deeper on NCT00695617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695617.